From: APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC
Characteristic | The number of patients, n (%) |
---|---|
Age | 63.15 ± 10.30 |
Age range | |
≥ 60 years | 675 (67.10) |
< 60 years | 331 (32.90) |
Sex | |
Male | 480 (47.71) |
Female | 526 (52.29) |
Histological cell type | |
Adenocarcinoma | 765 (76.04) |
Squamous cell carcinoma | 101 (10.04%) |
Others | 140 (13.92) |
Tumor stage | |
I + II | 907 (90.16) |
III + IV | 98 (9.74) |